These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34990865)

  • 1. Polypharmacology: The science of multi-targeting molecules.
    Kabir A; Muth A
    Pharmacol Res; 2022 Feb; 176():106055. PubMed ID: 34990865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
    Cerisier N; Petitjean M; Regad L; Bayard Q; Réau M; Badel A; Camproux AC
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational polypharmacology: a new paradigm for drug discovery.
    Chaudhari R; Tan Z; Huang B; Zhang S
    Expert Opin Drug Discov; 2017 Mar; 12(3):279-291. PubMed ID: 28067061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
    Ravikumar B; Aittokallio T
    Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.
    Miljković F; Bajorath J
    J Comput Aided Mol Des; 2020 Jan; 34(1):1-10. PubMed ID: 31792884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors.
    Reyes-Parada M; Iturriaga-Vasquez P
    Expert Opin Drug Discov; 2016 Oct; 11(10):969-81. PubMed ID: 27552487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacology: challenges and opportunities in drug discovery.
    Anighoro A; Bajorath J; Rastelli G
    J Med Chem; 2014 Oct; 57(19):7874-87. PubMed ID: 24946140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery.
    Lauria A; Bonsignore R; Bartolotta R; Perricone U; Martorana A; Gentile C
    Curr Pharm Des; 2016; 22(21):3073-81. PubMed ID: 26907944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets.
    Saqib U; Kelley TT; Panguluri SK; Liu D; Savai R; Baig MS; Schürer SC
    Front Pharmacol; 2018; 9():1201. PubMed ID: 30405416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Web-Based Tools for Polypharmacology Prediction.
    Awale M; Reymond JL
    Methods Mol Biol; 2019; 1888():255-272. PubMed ID: 30519952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing Promiscuity at the Level of Active Compounds and Targets.
    Bajorath J
    Mol Inform; 2016 Dec; 35(11-12):583-587. PubMed ID: 27870240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An up-to-date overview of computational polypharmacology in modern drug discovery.
    Chaudhari R; Fong LW; Tan Z; Huang B; Zhang S
    Expert Opin Drug Discov; 2020 Sep; 15(9):1025-1044. PubMed ID: 32452701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
    Zhang W; Bai Y; Wang Y; Xiao W
    Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward structure-multiple activity relationships (SMARts) using computational approaches: A polypharmacological perspective.
    López-López E; Medina-Franco JL
    Drug Discov Today; 2024 Jul; 29(7):104046. PubMed ID: 38810721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic computational identification of promiscuity cliff pathways formed by inhibitors of the human kinome.
    Miljković F; Vogt M; Bajorath J
    J Comput Aided Mol Des; 2019 Jun; 33(6):559-572. PubMed ID: 30915709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GES polypharmacology fingerprints: a novel approach for drug repositioning.
    Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
    J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacology in Precision Oncology: Current Applications and Future Prospects.
    Antolin AA; Workman P; Mestres J; Al-Lazikani B
    Curr Pharm Des; 2016; 22(46):6935-6945. PubMed ID: 27669965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacology: in silico methods of ligand design and development.
    McKie SA
    Future Med Chem; 2016 Apr; 8(5):579-602. PubMed ID: 27105127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand cluster-based protein network and ePlatton, a multi-target ligand finder.
    Du Y; Shi T
    J Cheminform; 2016; 8():23. PubMed ID: 27143991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ultra-fast 2D and 3D ligand and target descriptors for side effect prediction and network analysis in polypharmacology.
    Cortés-Cabrera A; Morris GM; Finn PW; Morreale A; Gago F
    Br J Pharmacol; 2013 Oct; 170(3):557-67. PubMed ID: 23826885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.